Nabeel Ahmed - 01 Apr 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
Chief Financial Officer
Signature
By: John L Brottem For: Nabeel Ahmed
Issuer symbol
OM
Transactions as of
01 Apr 2022
Transactions value $
-$10,713
Form type
4
Filing time
04 Apr 2022, 17:16:33 UTC
Previous filing
25 Mar 2022
Next filing
03 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $948 +100 +0.22% $9.48 44.6K 01 Apr 2022 Direct
transaction OM Common Stock Sale -$4.52K -100 -0.22% $45.19 44.5K 01 Apr 2022 Direct F1
transaction OM Common Stock Options Exercise $1.9K +200 +0.45% $9.48 44.7K 01 Apr 2022 Direct
transaction OM Common Stock Sale -$9.04K -200 -0.45% $45.19 44.5K 01 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Performance Options (right to buy) Options Exercise $0 -100 -0.94% $0.00 10.5K 01 Apr 2022 Common Stock 100 $9.48 Direct F2
transaction OM Performance Options (right to buy) Options Exercise $0 -200 -1.9% $0.00 10.3K 01 Apr 2022 Common Stock 200 $9.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 22, 2022.
F2 This performance option vested on March 15, 2021, upon meeting the performance measures set forth in the Grant Agreement.